## KVUE: Kenvue Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -2.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($15.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Invesco Ltd. Has $372.95 Million Stock Position in Kenvue Inc. $KVUE**
- Source: MarketBeat | 20251206T113203 | Neutral | Relevance: 99%
-  Invesco Ltd. increased its holdings in Kenvue Inc. (NYSE:KVUE) by 11.0% in the second quarter, bringing its total stake to 17,818,771 shares valued at $372.95 million. Other institutional investors also adjusted their positions in Kenvue, with several firms raising their stakes, contributing to institutional ownership of 97.64% of the company's stock. Analysts have set an average "Hold" rating for Kenvue with a consensus price target of $20.23, reflecting a mixed outlook on the stock.

**2. Kenvue Inc. $KVUE Shares Bought by Burgundy Asset Management Ltd.**
- Source: MarketBeat | 20251207T100814 | Somewhat-Bullish | Relevance: 98%
-  Burgundy Asset Management Ltd. significantly increased its stake in Kenvue Inc. ($KVUE) by 9.0% in the second quarter, now owning 7,148,796 shares valued at $149.62 million. Several other institutional investors also adjusted their positions, with 97.64% of the stock currently held by hedge funds and institutional investors. Analysts have issued mixed ratings, resulting in an average "Hold" consensus and a price target of $20.23, while Kenvue recently declared a quarterly dividend of $0.2075.

**3. Paxton Secures Major Win Against Johnson & Johnson and Kenvue**
- Source: Texas Border Business | 20251208T191740 | Neutral | Relevance: 98%
-  Attorney General Ken Paxton secured a legal victory against Johnson & Johnson and Kenvue, obtaining a Temporary Restraining Order for their operations in Texas without required registrations. The companies failed to comply with the Texas Business Organizations Code, which mandates foreign entities to register before conducting business in the state. Paxton emphasizes his commitment to holding powerful corporations accountable and protecting Texans' well-being over corporate greed.

**4. Kenvue Inc. $KVUE Position Raised by Ossiam**
- Source: MarketBeat | 20251208T115129 | Neutral | Relevance: 98%
-  Ossiam significantly increased its stake in Kenvue Inc. (NYSE:KVUE) by 679.3% in the second quarter, bringing its total holdings to 1,332,897 shares valued at approximately $27.9 million. This move is part of broader institutional investment trends, with various other firms also adjusting their positions in Kenvue, which currently holds a consensus "Hold" rating from analysts with an average target price of $20.23. The company recently reported Q3 earnings per share of $0.28, beating estimates, and announced a quarterly dividend reflecting a 4.9% yield.

**5. Kenvue and J&J must register in Texas or face business ban, judge rules**
- Source: Investing.com Nigeria | 20251208T180842 | Neutral | Relevance: 98%
- A Texas judge has ordered Kenvue Inc. and Johnson & Johnson to register with the Texas Secretary of State or face a business ban in the state. This ruling stems from lawsuits filed by Texas Attorney General Ken Paxton, who alleges J&J's registration lapsed and Kenvue never registered, in addition to claims of the companies hiding risks associated with Tylenol use during pregnancy. A hearing is scheduled for December 15 to consider further restrictions on their Texas operations.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-10 | Barclays | $18 | $17 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-10 | Barclays | main | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (+0.0%)
- Blackrock Inc.: 7.6% (-1.9%)
- Price (T.Rowe) Assoc: 6.0% (-31.5%)
- State Street Corpora: 6.0% (-0.2%)
- FMR, LLC: 4.7% (-9.3%)

### Key Risks

1. Long-term trend broken: trading 18.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.79 indicates undervaluation relative to growth. Forward P/E 15.1x stretched relative to 7% growth. Analyst sentiment positive (1 raises, avg +6%). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.2B |
| Beta | 0.56 |
| 52W Range | $14.02 - $25.17 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.79 |
| Forward P/E | 15.1 |
| Current P/E | 16.2 |
| YoY Growth | 7.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 5.4pp (needs >3.0% for momentum thesis). Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.40% (CS: 30) | Weak |
| RSI_14 | 52.6 | Neutral |
| MACD Histogram | 0.00 | Bearish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 1.043x | Above |
| vs SMA200 | 0.818x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $16.76
- **Stop Loss:** $15.84 (5.5% risk)
- **Target:** $17.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 543
- **Position Value:** $9,100.68
- **Portfolio %:** 9.10%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-05 (Est: $0.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.26 | $0.28 | +5.7% |
| 2025Q2 | $0.28 | $0.29 | +2.2% |
| 2025Q1 | $0.23 | $0.24 | +5.4% |
| 2024Q4 | $0.26 | $0.26 | +1.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*